Skip Page Header

Home > Naloxone for opioid‐exposed newborn infants.

Moe-Byrne, Thirimon and Brown, Jennifer Valeska Elli and McGuire, William [The Cochrane Library] . (2018) Naloxone for opioid‐exposed newborn infants. London: John Wiley & Sons, Ltd. Cochrane Database of Systematic Reviews (10) Art. No.: CD003483. DOI: 10.1002/14651858.CD003483.pub3

URL: https://www.cochranelibrary.com/cdsr/doi/10.1002/1...

Review question: Does naloxone (a drug that counters the negative effects of opioids on breathing) help newborn babies whose mothers have received opioid pain relief during birth?

Key results: The trials reported the effects of naloxone on the baby's breathing but did not assess the effect on the need for babies to be cared for in a neonatal unit (separated from their mother), whether they needed help with breathing, or on breastfeeding success. None of the trials assessed long‐term development. We did not find any trials including babies born to mothers who had used opioids (whether prescribed or non‐prescribed) during pregnancy.


Item Type
International research
Publication Type
Review
Drug Type
Opioid
Intervention Type
General / Comprehensive, Drug therapy, Treatment method, Harm reduction
Date
October 2018
Identification #
Art. No.: CD003483. DOI: 10.1002/14651858.CD003483.pub3
Publisher
John Wiley & Sons, Ltd
Place of Publication
London
Number
10
EndNote

Repository Staff Only: item control page